Global Heart Pump Devices Market are anticipated to grow at a substantial CAGR of 15.24% and will reach USD 6.36 billion during the forecast period from 2021 to 2026. The demand for Heart Pump Devices is primarily attributed to factors such as the rising prevalence of cardiovascular diseases, increased time duration pertaining to heart transplants, and the entrance of key companies such as Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc., and others are expected to increase the Heart Pump Devices demand, thus driving the growth of the Heart Pump Devices market.
DelveInsight’s Heart Pump Devices Market Insights and Forecast provides the current and forecasted Heart Pump Devices Market forecasts for the next five years, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Heart Pump Devices Market.
Heart Pump Devices Overview
Heart failure is a condition wherein the heart is not able to pump an adequate amount of blood to meet the requirements of the body. The cause of heart failure depends on a number of factors such as pre-myocardial infarction (heart attack), high blood pressure, heart diseases, atrial fibrillation and others such as a coronary artery. In order to help cardiac circulation, several types of cardiovascular pumping systems are available in the market. The devices are implanted surgically and are used in humans suffering from low heart
Heart Pump Devices Market Insights
Geographically, the Global Heart Pump Devices market is studied and segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounts for the highest revenue share when compared with the Global Heart Pump Devices market and it will remain constant during the forecast period. However, the domination of North America will be conspicuously challenged by the European market. This domination is attributed to the increased cardiovascular disease prevalence in the region, the rising number of regulatory approvals and the favourable refund scheme.
Various Heart Pump Devices market growth opportunities can also be witnessed for other countries including European countries owing to the rising number of patients suffering from cardiovascular disease and the recent launch of new products in this region.
For instance, on April 04, 2018, Abiomed had announced the European approval (CE Mark) for Impella 5.5 heart pump. The rising cases of CVD and growing product approvals in the region are the key factor for the strong growth of the region which will also continue during the forecast period from 2021 to 2026.
To know more about why North America is leading the market growth in the Heart Pump Devices market, get a snapshot of the report Heart Pump Devices Market Report
Recent Breakthroughs In Heart Pump Devices Market
- On June 30, 2021, Abiomed’s heart pump Impella RP with SmartAssist technology had received the United States FDA pre-market approval.
- On February 04, 2020, Abbott had received the Food and Drug Administration’s Breakthrough device designation for its Fully Implantable Left Ventricular Assist System (FILVAS), currently under the process of development.
- On February 11, 2019, Leviticus Cardio and Jarvik Heart had unveiled the use of the first FIVAD device for wireless power implanted in humans in Kazakhstan. The device uses coplanar energy transfer for wirelessly providing power to the heart pump, also known as the Ventricular Assist Device (VAD). Thus, owing to such development like product launches, there will be significant growth observed in the Heart Pump Devices market during the forecast period.
Interested in knowing how the Heart Pump Devices Market will be growing by 2026? Click to get a snapshot of Heart Pump Devices Market Assessment
Key Players Proactively Working In the Heart Pump Devices Market
Key Heart Pump Devices companies contribute a lot to the development of these devices, they are also involved in mergers and acquisitions to strengthen their market position. Some of the companies operating actively in the Heart Pump Devices market include Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid SRL, Getinge AB and others.
COVID-19 Impact On Heart Pump Devices Market
COVID-19 pandemic has been observed to be an incomparable public health emergency that has affected almost every industry and its long-term effects of it are projected to impact the healthcare market. As for the Heart Pump Devices market, they had observed a period of slow growth because of heart pump device stock-outs, unavailability of the heart pump devices and the closed clinics.
Furthermore, the transport-trade restrictions and lockdown of the entire geographies were also the reasons for stagnancy witnessed in the heart pump devices market. All forms of elective surgeries were stopped temporarily giving major priority to COVID-19 affected patients.
However, the manufacturing companies and clinics are slowly resuming their operations. Patient visits are also gradually increasing after the relaxation given as per the new lockdown guidelines. There is still an increasing amount of research going on regarding the use of Heart Pump Devices in COVID-19 patients. Hence, the Heart Pump Devices are slowly gaining normalcy in terms of market growth.
To discuss more regarding the short/long-term impact of COVID-19 get a snapshot of the report Heart Pump Devices Market Assessment
Scope of the Heart Pump Devices Market Report:
- Geography Covered: Global
- Study Period: 2021-2026
- Market Segmentation By Product Type – Ventricular Assist Devices (Left Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Biventricular Ventricular Assist Devices, Right Ventricular Assist Devices), Intra-Aortic Balloon Pumps, Total Artificial Hearts, and others.
- Market Segmentation By Type – Implanted Heart Pump Device, Extracorporeal Heart Pump Device
- Market Segmentation By Therapy – Bridge-To-Transplant, Bridge-To-Candidacy, Destination Therapy
- Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
- Heart Pump Devices Companies in the Market – Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid SRL, Getinge AB, and others
- Porter’s Five Forces Analysis
- Product Profiles
- Case Studies
- KOL’s Views
- Analyst’s View
- DelveInsight Analysis: The Heart Pump Devices market is expected to grow at a CAGR of 15.24% and will reach USD 6.36 billion by 2026.
Table of Contents
| 1 | Heart Pump Devices Market Report Introduction |
| 2 | Heart Pump Devices Market Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Heart Pump Devices Market Key Factors Analysis |
| 5 | Heart Pump Devices Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Heart Pump Devices Market |
| 7 | Heart Pump Devices Market Layout |
| 8 | Heart Pump Devices Global Company Share Analysis – Key 3-5 Companies |
| 9 | Heart Pump Devices Companies and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
To get a deeper understanding of key companies related to the Heart Pump Devices Market, get a snapshot of the Heart Pump Devices Market Landscape
Key Takeaways From the Heart Pump Devices Market Report Study
- Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Heart Pump Devices market.
- Top key product/services/technology developments, mergers, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Heart Pump Devices Market.
- Various opportunities are available for the other competitor in the Heart Pump Devices Market space.
- What are the top-performing segments in 2020? How these segments will perform in 2026.
- Which are the top-performing regions and countries in the current market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Heart Pump Devices market growth in the coming future
Target Audience Who Can Be Benefited from Heart Pump Devices Market Report Study
- Heart Pump Devices providers
- Research organizations and consulting companies
- Heart Pump Devices related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders in Heart Pump Devices
- Various End-users want to know more about the Heart Pump Devices Market and the latest technological developments in the Heart Pump Devices market.
Learn More About DelveInsight Report Offerings
DelveInsight’s ‘Cardiac Valvulotome – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cardiac Valvulotome and the historical and forecasted Cardiac Valvulotome market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Braun Melsungen AG, LeMaitre Vascular, Inc., Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and others.
Cardiac Resynchronization Therapy Market
DelveInsight’s ‘Cardiac Resynchronization Therapy – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cardiac Resynchronization Therapy and the historical and forecasted Cardiac Resynchronization Therapy market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems, Abbott, and others.
Cardiac Restoration Systems Market
DelveInsight’s ‘Cardiac Restoration Systems – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Abbott, BioVentrix, CryoLife, Edwards Lifesciences Corporation,NeoChord, XELTIS, and others.
Cardiac Output Monitors Market
DelveInsight’s ‘Cardiac Output Monitors – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cardiac Output Monitors and the historical and forecasted Cardiac Output Monitors market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Osypka Medical GmbH, CNSystems Medizintechnik GmbH., Uscom,Deltex Medical Limited, Edward Lifesciences Corporation, ICU Medical, Inc., LiDCO, Baxter., Getinge AB., GE Healthcare (GENERAL ELECTRIC COMPANY), Biotronik, and others.
Cardiac Monitoring Devices Market
Global Cardiac Monitoring Devices Market report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Medtronic, Boston Scientific, Abbott Laboratories, GE Healthcare, BIOTRONIK, and Koninklijke Philips, Asahi Kasei Corporation, MicroPort Scientific Corporation, Hill-Rom Holdings, Nihon Kohden, SCHILLER AG, BioTelemetry, BPL Medical Technologies, ACS Diagnostics, and others.
Cardiac Biomarkers Testing Market
Global Cardiac Biomarkers Testing Market was valued at USD 3.25 billion in 2020, growing at a CAGR of 7.76% during the forecast period from 2021 to 2026 to reach USD 5.07 billion by 2026. The report delivers an in-depth understanding of Global Cardiac Biomarkers Testing market trends, market drivers & barriers, unmet needs, and key companies involved such as Beckman Coulter, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, and others.
Global Cardiac Assist Devices Market was valued at USD 2.55 billion in 2020, growing at a CAGR of 13.70% during the forecast period from 2021 to 2026, to reach USD 5.50 billion by 2026. The report delivers an in-depth understanding of Global Cardiac Assist Devices and the historical and forecasted Global Cardiac Assist Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, NovaPump GmbH, Getinge AB Balton Ltd, Meril Life Sciences Pvt. Ltd, Thoratec Corporation, and others.
3D Cardiac Mapping System Market
DelveInsight’s ‘3D Cardiac Mapping System – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of 3D Cardiac Mapping System and the historical and forecasted 3D Cardiac Mapping System market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Biosense Webster, (Jhonson & Jhonson), Boston Scientific Corporation, Abbott, Kardium, Medtronic, Catheter Robotics, Inc, Lepu Medical, EP Solutions SA, and others.
Browse Through Our Blog Posts
- With advancements in Innovative Technology, Cardiac Monitoring Devices Market is Booming Significantly
- Mapping the Increasing Burden of Heart Failure: What Does it Bring for Healthcare Market Companies?
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
+1(919)321-6187